New bladder cancer guideline, Bylaws vote, Speed of Light opps
September 16, 2026
| ASTRO releases guideline on radiation therapy for bladder cancer |
| ASTRO’s first Radiation Therapy for Bladder Cancer Guideline addresses the treatment of patients with bladder cancer in the upfront, definitive setting, as well as in the postoperative and metastatic settings. Review a detailed summary of the key points from the guideline in ASTRO’s news release. |
| Committee service opportunities open for Speed of Light – The ASTRO Foundation and HACE Council |
| Help advance ASTRO’s mission by sharing your expertise and perspective. Speed of Light – The ASTRO Foundation and ASTRO’s Healthcare Access and Community Engagement (HACE) Council are now accepting volunteers to serve on committees and subcommittees for the Society year beginning January 1, 2027! Submit your preferences on the Call for Committee Volunteers webpage by October 16. |
 |
| Prepping for the Annual Meeting – 10 days to go! |
The ASTRO Annual Meeting is just 10 days away! Here are a few quick tips to help you get ready:
|
| Making the most of the Exhibit Hall offerings |
| The Exhibit Hall is the central hub for discovery at ASTRO 2026, featuring nearly 200 companies showcasing the latest innovations, more than a dozen Industry Expert Theaters and approximately 1,700 posters. Posters will be available for viewing during Exhibit Hall hours, and for a more interactive time, during Poster Q&A Sessions. New for 2026, the Presidential Science Poster Session Showcase will feature hand-picked, top-rated translational science posters from across disease sites and disciplines, presented by expert faculty in conjunction with the Exhibit Hall Networking Reception. |
| Introducing the ASTRO 2026 Social Champions! |
| The #ASTRO26 Social Champions serve as Annual Meeting ambassadors on X and other social channels during the conference. They will share important science and topics of interest throughout the meeting. We also welcome representatives from Mednet and our media partners, OncoAlert and Cancer Network, who will highlight science presented at the meeting. Follow ASTRO and our Social Champions on X to see highlights of the Annual Meeting and use the hashtag #ASTRO26 to join the discussions. Meet our 2026 Social Champions! |
| ASTRO advocates for fair payments and patient safety in recent CMS and NRC comments |
| On September 10, ASTRO submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the 2027 Medicare Physician Fee Schedule proposed rule. ASTRO called on the Agency to increase payments for radiation treatment delivery services by correcting a hospital payment assignment that currently undervalues intermediate treatment delivery and severely impacts community-based centers.
In addition, ASTRO submitted comments to the Nuclear Regulatory Commission (NRC) on proposed changes to the medical use licensing rule and draft patient release guidance. While ASTRO supports the NRC’s proposals, the Society recommended refinements to avoid unintended safety risks and regulatory confusion, emphasizing that patient safety and practical implementation must remain central. |
| Tomorrow is World Patient Safety Day |
| Tomorrow, September 17, is World Patient Safety Day – an opportunity to celebrate efforts that strengthen safe, effective care for patients. RO-ILS, a cornerstone safety program supported by ASTRO, AAPM, ASRT, AAMD, Varian, Sun Nuclear, Radformation, and Vision RT, drives improvement by collecting, analyzing and sharing lessons learned. ASTRO’s APEx accreditation program advances safe, high-quality care through continuous quality improvement. Demonstrate your commitment to a culture of safety by participating in these vital programs. |
| Last week’s webinar series on the Role of Radiation in Oligometastatic and Polymetastatic Disease now available |
| Now available for purchase OnDemand, this two-part webinar series features speakers from London Health Sciences Centre and Seidman Cancer Center. The expert faculty discusses advancements in metastasis-directed therapy, current indications and challenging cases. Register today to access the recordings and and claim up to 2 CMEs for the series. |
